Tech Company Financing Transactions
Comphya Funding Round
Comphya closed a $918 thousand funding round on 1/31/2023. Investors included Praxis Spinal Cord Institute.
Transaction Overview
Company Name
Announced On
1/31/2023
Transaction Type
Venture Equity
Amount
$918,000
Round
Undisclosed
Investors
Praxis Spinal Cord Institute (Lead Investor)
Proceeds Purpose
The company intends to use the funds to secure the start of the pilot clinical trials in Q1 2023.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
EFPL Innovation Park Bâtiment C
Lausanne, 1015
CH
Lausanne, 1015
CH
Phone
Undisclosed
Website
Email Address
Overview
Our focus is to bring a better and comfortable therapy for erectile dysfunction to patients non-amendable to oral drugs. Comphya is a Swiss medical device company, spin-off from the École Polytechnique Fédérale de Lausanne, specialized in the treatment of erectile dysfunction to patients non-responsive to oral therapy. With an innovation based on neuroprosthetics principle, our mission is to offer a unique and superior treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Steven Swinson
Chief Executive Officer
Rodrigo Silva
Chief Technical Officer
Mikael Sturny
Browse more venture capital transactions:
Prev: 1/31/2023: Cohere Technologies venture capital transaction
Next: 1/31/2023: Convey911 venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs